Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Nifedipine SR capsules in 30 and 60mg doses More
Submolecular Markers that Leverages the Earliest Diagnostic Test of Acute Myocardial Infarction More
Isosorbide Dinitrate SR capsules in 20-40-60 and 80mg doses More
Nifedipine SR capsules available in 10 and 20mg doses More
SR capsules of Isosorbide-5-Mononitrate in 40-50 and 60mg doses More
Whole-body Magnetic Resonance Angiography (MRA) software/system enhancement techniques that provide rapid, high resolution, 3D, imaging capabilities. More
A pharmacogenetic method to identify candidates who are most likely to benefit from treatment with statins to reduce cancer risk, and consequently minimizing any unnecessary cost and side effects in individuals who do not benefit. More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Angioplasty
- Anti-angiogenesis
- Cardioprotection
- Cardiovascular surgery
- Coronary artery angioplasty/bypass
- Percutaneous transluminal angioplasty
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us